Annual Retained Earnings
-$1.29 B
-$303.09 M-30.72%
December 31, 2021
Summary
- As of February 10, 2025, GBT annual retained earnings is -$1.29 billion, with the most recent change of -$303.09 million (-30.72%) on December 31, 2021.
- During the last 3 years, GBT annual retained earnings has fallen by -$817.41 million (-173.13%).
Performance
GBT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.45 B
-$82.47 M-6.02%
June 30, 2022
Summary
- As of February 10, 2025, GBT quarterly retained earnings is -$1.45 billion, with the most recent change of -$82.47 million (-6.02%) on June 30, 2022.
- Over the past year, GBT quarterly retained earnings has dropped by -$322.46 million (-28.51%).
Performance
GBT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
GBT Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -30.7% | -28.5% |
3 y3 years | -173.1% | -151.3% |
5 y5 years | -332.8% | -537.1% |
GBT Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | at low | +12.7% | at low |
5 y | 5-year | +74.5% | at low | +96.7% | at low |
alltime | all time | +4497.9% | at low | +2846.5% | at low |
Global Blood Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | -$1.45 B(+6.0%) |
Mar 2022 | - | -$1.37 B(+6.3%) |
Dec 2021 | -$1.29 B(+30.7%) | -$1.29 B(+7.3%) |
Sep 2021 | - | -$1.20 B(+6.3%) |
Jun 2021 | - | -$1.13 B(+6.6%) |
Mar 2021 | - | -$1.06 B(+7.6%) |
Dec 2020 | -$986.47 M(+33.5%) | -$986.47 M(+6.7%) |
Sep 2020 | - | -$924.66 M(+6.9%) |
Jun 2020 | - | -$864.78 M(+6.5%) |
Mar 2020 | - | -$811.94 M(+9.9%) |
Dec 2019 | -$738.92 M(+56.5%) | -$738.92 M(+14.9%) |
Sep 2019 | - | -$642.94 M(+11.2%) |
Jun 2019 | - | -$578.39 M(+11.0%) |
Mar 2019 | - | -$521.07 M(+10.4%) |
Dec 2018 | -$472.15 M | -$472.15 M(+11.6%) |
Sep 2018 | - | -$422.95 M(+11.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2018 | - | -$379.88 M(+11.9%) |
Mar 2018 | - | -$339.51 M(+13.9%) |
Dec 2017 | -$297.96 M(+64.7%) | -$297.96 M(+16.1%) |
Sep 2017 | - | -$256.70 M(+12.5%) |
Jun 2017 | - | -$228.15 M(+11.7%) |
Mar 2017 | - | -$204.26 M(+12.9%) |
Dec 2016 | -$180.93 M(+83.8%) | -$180.93 M(+17.7%) |
Sep 2016 | - | -$153.73 M(+15.8%) |
Jun 2016 | - | -$132.74 M(+15.4%) |
Mar 2016 | - | -$115.06 M(+16.9%) |
Dec 2015 | -$98.47 M(+99.6%) | -$98.47 M(+18.8%) |
Sep 2015 | - | -$82.88 M(+22.5%) |
Jun 2015 | - | -$67.68 M(+17.4%) |
Mar 2015 | - | -$57.65 M(+16.9%) |
Dec 2014 | -$49.33 M(+75.9%) | -$49.33 M |
Dec 2013 | -$28.05 M | - |
FAQ
- What is Global Blood Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Global Blood Therapeutics?
- What is Global Blood Therapeutics annual retained earnings year-on-year change?
- What is Global Blood Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Global Blood Therapeutics?
- What is Global Blood Therapeutics quarterly retained earnings year-on-year change?
What is Global Blood Therapeutics annual retained earnings?
The current annual retained earnings of GBT is -$1.29 B
What is the all time high annual retained earnings for Global Blood Therapeutics?
Global Blood Therapeutics all-time high annual retained earnings is -$28.05 M
What is Global Blood Therapeutics annual retained earnings year-on-year change?
Over the past year, GBT annual retained earnings has changed by -$303.09 M (-30.72%)
What is Global Blood Therapeutics quarterly retained earnings?
The current quarterly retained earnings of GBT is -$1.45 B
What is the all time high quarterly retained earnings for Global Blood Therapeutics?
Global Blood Therapeutics all-time high quarterly retained earnings is -$49.33 M
What is Global Blood Therapeutics quarterly retained earnings year-on-year change?
Over the past year, GBT quarterly retained earnings has changed by -$322.46 M (-28.51%)